Differential resting quantitative electroencephalographic alpha patterns in women with environmental chemical intolerance, depressives, and normals

Biological Psychiatry

Volumn 43, Issue 5, 1998, Pages 376-388

  Bell, Iris R ^a,b   Schwartz, Gary E ^a   Hardin, Elizabeth E ^a   Baldwin, Carol M ^a   Kline, John P ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b SOUTHERN ARIZONA VA HEALTH CARE SYSTEM   (United States)

Author keywords

Arousal; Attention; Chemical odor intolerance; Depression; EEG alpha; Frontal asymmetry; Multiple chemical sensitivity

Indexed keywords

ADULT; ALPHA RHYTHM; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DISTRESS SYNDROME; ELECTROENCEPHALOGRAM; FEMALE; HUMAN; MULTIPLE CHEMICAL SENSITIVITY; PRIORITY JOURNAL; PSYCHOLOGIC TEST; SOMATIZATION;

ADULT; AFFECT; ALPHA RHYTHM; AROUSAL; ATTENTION; DEPRESSIVE DISORDER; ENVIRONMENTAL ILLNESS; FEMALE; HUMANS; MIDDLE AGED; PREFRONTAL CORTEX; PSYCHIATRIC STATUS RATING SCALES;

EID: 0032032121     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(97)00245-X     Document Type: Article

References (120)

1. Allen JJ, Iacono WG, Depue RR, Arbisi P. Regional EEG asymmetrics in bipolar seasonal affective disorder before and after phototherapy. Biol Psychiatry. 33:1993;642-646.
2. Antelman SM. Time-dependent sensitization as the cornerstone for a new approach to pharmacotherapy Drugs as foreign/stressful stimuli . Drug Dev Res. 14:1988;1-30.
3. Antelman SM. Time-dependent sensitization in animals A possible model of multiple chemical sensitivity in humans . Toxicol Ind Health. 10:1994;335-342.
4. Antelman SM, Caggiula AR, Kocan D, et al. One experience with "lower' or "higher' intensity stressors respectively enhances or diminishes responsiveness to haloperidol weeks later Implications for understanding drug variability . Brain Res. 566:1991;276-283.
5. Antelman SM, Caggiula AR, Kiss S, Edwards D, Kocan D, Stiller R. Neurochemical and physiological effects of cocaine oscillate with sequential drug treatment Possibly a major factor in drug variability . Neuropsychopharmacology. 12:1995;297-306.
6. Ashford NA, Miller CS (in press): Chemical Exposures: Low Levels and High Stakes 2nd ed. New York: Van Nostrand Reinhold.
7. Barsky AJ, Goodson JD, Lane RS, Cleary PD. The amplification of somatic symptoms. Psychosom Med. 50:1988;510-519.
8. Bell IR. Neuropsychiatric aspects of sensitivity to low level chemicals A neural sensitization model . Toxicol Ind Health. 10:1994;277-312.
9. Bell IR. Clinically relevant EEG studies and psychophysiological findings Possible neural mechanisms for multiple chemical sensitivity . Toxicology. 111:1996;101-117.
10. Bell IR, Amend D (1994): More cortisol suppression in depressed cacosmics: DST evaluation of chemically sensitive older adults. Presentation at the New Research sessions of the 147th Annual Meeting of the American Psychiatric Association, Philadelphia, May 21-26.
11. Bell IR, Miller CS, Schwartz GE. An olfactory-limbic model of multiple chemical sensitivity syndrome Possible relationship to kindling and affective spectrum disorders . Biol Psychiatry. 32:1992;218-242.
12. Bell IR, Schwartz GE, Peterson JM, Amend D. Self-reported illness from chemical odors in young adults without clinical syndromes or occupational exposures. Arch Environ Health. 48:1993a;6-13.
13. Bell IR, Schwartz GE, Peterson JM, Amend D, Stini WA. Possible time-dependent sensitization to xenobiotics Self-reported illness from chemical odors, foods, and opiate drugs in an older adult population . Arch Environ Health. 48:1993b;315-327.
14. Bell IR, Schwartz GE, Peterson JM, Amend D. Symptom and personality profiles of young adults from a college student population with self-reported illness from foods and chemicals. J Am Coll Nutr. 12:1993c;693-702.
15. Bell IR, Amend D, Kaszniak AW, Schwartz GE. Memory deficits, sensory impairment, and depression in the elderly. Lancet. 341:1993d;62.
16. Bell IR, Schwartz GE, Amend D, Peterson JM, Stini WA. Sensitization to early life stress and response to chemical odors in older adults. Biol Psychiatry. 35:1994;857-863.
17. Bell IR, Peterson JM, Schwartz GE. Medical histories and psychological profiles of middle-aged women with and without self-reported illness from environmental chemicals. J Clin Psychiatry. 56:1995a;151-160.
18. Bell IR, Hardin E, Baldwin CM, Schwartz GE. Increased limbic system symptomatology and sensitizability of young adults with chemical and noise sensitivities. Environ Res. 70:1995b;84-97.
19. Bell IR, Wyatt JK, Bootzin RR, Schwartz GE. Slowed reaction time performance on a divided attention task in elderly with environmental chemical odor intolerance. Int J Neurosci. 84:1995c;127-134.
20. Bell IR, Miller CS, Schwartz GE, Peterson JM, Amend D. Neuropsychiatric and somatic characteristics of young adults with and without self-reported chemical odor intolerance and chemical sensitivity. Arch Environ Health. 51:1996a;9-21.
21. Bell IR, Bootzin RR, Davis T, et al. Time-dependent sensitization of plasma beta-endorphin in community elderly with self-reported environmental chemical odor intolerance. Biol Psychiatry. 40:1996b;134-143.
22. Bell IR, Bootzin RR, Ritenbaugh C, et al. A polysomnographic study of sleep disturbance in community elderly with self-reported environmental chemical odor intolerance. Biol Psychiatry. 40:1996c;123-133.
23. Bell IR, Schwartz GE, Baldwin CM, Hardin EE. Neural sensitization and physiological markers in multiple chemical sensitivity. Regul Toxicol Pharmacol. 24:(Suppl 1):1996d;S39-S47.
24. Bell IR, Schwartz GE, Bootzin RR, Wyatt JK. Time-dependent sensitization of heart rate and blood pressure over multiple laboratory sessions in elderly individuals with and without chemical odor intolerance. Arch Environ Health. 52:1997a;6-17.
25. Bell IR, Schwartz GE, Baldwin CM, Hardin EE, Klimas N, Kline JP, et al. Individual differences in neural sensitization and the role of context in illness from low level environmental chemical exposures. Environ Health Perspect. 105:(Suppl 2):1997b;457-466.
26. Bell IR, Walsh ME, Goss A, Gersmeyer J, Schwartz GE, Kanof P (in press a): Cognitive dysfunction and disability in geriatric veterans with self-reported sensitivity to environmental chemicals. J Chronic Fatigue Syndrome.
27. Bell IR, Baldwin CM, Schwartz GE (in press b): Illness from low levels of environmental chemicals: Relevance to chronic fatigue syndrome and fibromyalgia. Am J Med Suppl.
28. Bell IR, Baldwin CM, Schwartz GE, Hardin EE, Miller CS (in submission a): Interaction of chemical odor intolerance and depression in preclinical symptom patterns of young adults.
29. Bell IR, Bootzin RR, Schwartz GE, Szarek MJ, DiCenso DR, Baldwin CM (in submission b): Differing patterns of cognitive dysfunction and heart rate reactivity in chemically intolerant individuals with and without lifestyle changes: Is prefrontal cortex involved?
30. Bell IR, Baldwin CM, Russek LG, Schwartz GE, Hardin EE (in submission c): Early life stress, negative paternal relationships, and chemical odor intolerance in middle-aged women: Support for a neural sensitization model.
31. Benignus VA. EEG as a cross-species indicator of neurotoxicity. Neurobehav Toxicol Teratol. 6:1984;473-483.
32. Black DW, Rathe A, Goldstein RB. Environmental illness A controlled study of 26 subjects with "20th century disease." JAMA. 264:1990;3166-3170.
33. Brenner RP, Ulrich RF, Spiker DG, et al. Computerized EEG spectral analysis in elderly normal, demented, and depressed subjects. Electroencephalogr Clin Neurophysiol. 64:1986;483-492.
34. Buchwald D, Garrity D. Comparison of patients with chronic fatigue syndrome, fibromyalgia, and multiple chemical sensitivities. Arch Intern Med. 154:1994;2049-2053.
35. Burchfiel JL, Duffy FH. Organophosphate neurotoxicity Chronic effects of sarin on the electroencephalogram of monkey and man . Neurobehav Toxicol Teratol. 4:1982;767-778.
36. Cain WS, Gent JF, Goodspeed RB, Leonard G. Evaluation of olfactory dysfunction in the Connecticut Chemosensory Clinical Research Center. Laryngoscope. 98:1988;83-88.
37. Cheek JM, Buss AH. Shyness and sociability. J Pers Soc Psychol. 41:1981;330-339.
38. Cornish JL, vanden Buuse M. Stimulation of the rat mesolimbic dopaminergic system produces a pressor response which is mediated by dopamine D1 and D2 receptor activation and the release of vasopressin. Brain Res. 701:1995;28-38.
39. Cullen MR. The worker with multiple chemical sensitivities An overview . Cullen MR. Occupational Medicine State of the Art Reviews . 1987;655-662 Hanley and Belfus, Philadelphia.
40. Davidoff AL, Fogarty L. Psychogenic origins of multiple chemical sensitivities syndrome A critical review of the research literature . Arch Environ Health. 49:1994;316-325.
41. Davidson RJ, Fox NA. Frontal brain asymmetry predicts infants' response to maternal separation. J Abnorm Psychol. 98:1989;127-131.
42. Davidson RJ, Schwartz GE, Saron C, Bennett J, Goleman DJ. Frontal versus parietal EEG asymmetry during positive and negative affect. Psychophysiology. 16:1979;202-203.
43. Davidson RJ, Schaffer CE, Saron C. Effects of lateralized stimulus presentations on the self-report of emotion and EEG asymmetry in depressed and nondepressed subjects. Psychophysiology. 22:1985;353-364.
44. Demitrack MA, Dale JK, Straus SE, et al. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J Clin Endocrinol Metab. 73:1991;1224-1234.
45. Deutch AY, Clark WA, Roth RH. Prefrontal cortical dopamine depletion enhances the responsiveness of mesolimbic dopamine neurons to stress. Brain Res. 521:1990;311-315.
46. Doty RL, Deems DA, Frye RE, Pelberg R, Shapiro A. Olfactory sensitivity, nasal resistance, and autonomic function in patients with multiple chemical sensitivities. Arch Otolaryngol Head Neck Surg. 114:1988;1422-1427.
47. Ehlers CL, Schuckit MA. Evaluation of EEG alpha activity in sons of alcoholics. Neuropsychopharmacology. 4:1991;199-205.
48. Ehlers C, Phillips E, Parry BL. Electrophysiological findings during the menstrual cycle in women with and without late luteal phase dysphoric disorder Relationship to risk for alcoholism? Biol Psychiatry. 39:1996;720-732.
49. Ewing JA. Detecting alcoholism The CAGE questionnaire . JAMA. 252:1984;1905-1907.
50. Ferger B, Stahl D, Kuschinsky K. Effects of cocaine on the EEG power spectrum of rats are significantly altered after its repeated administration Do they reflect sensitization phenomena? Naunyn Schmeidebergs Arch Pharmacol. 353:1996;545-551.
51. Fiedler N, Maccia C, Kipen H. Evaluation of chemically sensitive patients. J Occup Med. 34:1992;529-538.
52. Fiedler N, Kipen H, DeLuca J, Kelly-McNeil K, Natelson B. Neuropsychology and psychology of MCS. Toxicol Ind Health. 10:1994;545-554.
53. Fiedler N, Kipen HM, DeLuca J, Kelly-McNeil K, Natelson B. A controlled comparison of multiple chemical sensitivities and chronic fatigue syndrome. Psychosom Med. 58:1996;38-49.
54. Gots RE. Multiple chemical sensitivities - Public policy. Clin Toxicol. 33:1995;111-113.
55. Hamamura T, Fibiger HC. Enhanced stress-induced dopamine release in the prefrontal cortex of amphetamine-sensitized rats. Eur J Pharmacol. 237:1993;65-71.
56. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 23:1960;56-62.
57. Harden PW, Pihl RO. Cognitive function, cardiovascular reactivity, and behavior in boys at risk for alcoholism. J Abnorm Psychol. 104:1995;94-103.
58. Henriques JB, Davidson RJ. EEG activation asymmetries discriminate between normothymic depressives and normal controls. Psychophysiology. 25:1988;453-454.
59. Henriques JB, Davidson RJ. Left frontal hypoactivation in depression. J Abnorm Psychol. 100:1991;535-545.
60. Heuser G, Mena I, Alamos F. Neurospect findings in patients exposed to neurotoxic chemicals. Toxicol Ind Health. 10:1994;561-571.
61. Kalivas PW, Alesdatter JE. Involvement of N-methyl-D-aspartate receptor stimulation in the ventral tegmental area and amygdala in behavioral sensitization to cocaine. J Pharmacol Exp Ther. 267:1993;486-495.
62. Kalivas PW, Barnes CD. Limbic Motor Circuits and Neuropsychiatry. 1993;CRC Press, Boca Raton, FL.
63. Kalivas PW, Sorg BA, Hooks MS. The pharmacology and neural circuitry of sensitization to psychostimulants. Behav Pharmacol. 4:1993;315-334.
64. Kampov-Polevoy A, Garbutt JC, Janowsky D. Evidence for preference for a high-concentration sucrose solution in alcoholic men. Am J Psychiatry. 154:1997;269-270.
65. Kay LM. Support for the kindling hypothesis in multiple chemical sensitivity syndrome (MCSS) induction. Soc Neurosci. 22:1996;1825.
66. Knott VJ, Lapierre YD. Computerized EEG correlates of depression and antidepressant treatment. Prog Neuropsychopharmacol Biol Psychiatry. 11:1987;213-221.
67. Lane RD, Merikangas KR, Schwartz GE, Huang SS, Prusoff BA. Inverse relationship between defensiveness and lifetime prevalence of psychiatric disorder. Am J Psychiatry. 147:1990;573-578.
68. Locatelli M, Bellodi L, Perna G, Scarone S. EEG power modifications in panic disorder during a temporolimbic activation task Relationships with temporal lobe clinical symptomatology . J Neuropsychiatry Clin Neurosci. 5:1993;409-414.
69. Matikainen E, Forsman-Gronholm L, Pfaffli P, Juntunen J. Nervous system effects of occupational exposure to styrene A clinical and neurophysiological study . Environ Med. 61:1993;84-92.
70. Meggs WJ, Dunn KA, Bloch RM, Goodman PE, Davidoff AL. Prevalence and nature of allergy and chemical sensitivity in a general population. Arch Environ Health. 51:1996;275-282.
71. Mesulam MM. Principles of Behavioral Neurology. 1985;292-295 Davis, Philadelphia.
72. Miller CS. Chemical sensitivity History and phenomenology . Toxicol Ind Health. 10:1994;253-276.
73. Miller CS, Mitzel HC. Chemical sensitivity attributed to pesticide exposure versus remodeling. Arch Environ Health. 50:1995;119-129.
74. Mitchell JB, Gratton A. Partial dopamine depletion of the prefrontal cortex leads to enhanced mesolimbic dopamine release elicited by repeated exposure to naturally reinforcing stimuli. J Neurosci. 12:1992;3609-3618.
75. Morrow LA, Steinhauer SR. Alterations in heart rate and pupillary response in persons with organic solvent exposure. Biol Psychiatry. 37:1995;721-730.
76. Morrow LA, Ryan CM, Hodgson MJ, Robin N. Alterations in cognitive and psychological functioning after organic solvent exposure. J Occup Med. 32:1990;444-450.
77. Morrow LA, Ryan CM, Hodgson MJ, Robin N. Risk factors associated with persistence of neuropsychological deficits in persons with organic solvent exposure. J Nerv Ment Dis. 179:1991;540-545.
78. Morrow LA, Robin N, Hodgson MJ, Kamis H. Assessment of attention and memory efficiency in persons with solvent neurotoxicity. Neuropsychologia. 30:1992a;911-922.
79. Morrow LA, Steinhauer SR, Hodgson MJ. Delay in P300 latency in patients with organic solvent exposure. Arch Neurol. 49:1992b;315-320.
80. Morrow LA, Kamis H, Hodgson MJ. Psychiatric symptomatology in persons with organic solvent exposure. J Consult Clin Psychol. 61:1993;171-174.
81. Muttray A, Lang J, Mayer-Popken O, Komietzko J. Acute changes in the EEG of workers exposed to mixtures of organic solvents. Int J Occup Med Environ Health. 8:1995;131-137.
82. Newlin DB, Thomson JB. Chronic tolerance and sensitization to alcohol in sons of alcoholics. Alcohol Clin Exp Res. 15:1991;399-405.
83. Niedermeyer E, Lopes da Silva F. Electroencephalography Basic Principles, Clinical Applications, and Related Fields . 3rd ed. 1993;Williams & Wilkins, Baltimore.
84. Nystrom C, Matousek M, Hallstrom T. Relationships between EEG and clinical characteristics in major depressive disorder. Acta Psychiatr Scand. 73:1986;390-394.
85. Orbaek P, Rosen I, Svensson K. Power spectrum analysis of EEG at diagnosis and follow up of patients with solvent induced chronic toxic encephalopathy. Br J Ind Med. 45:1988;476-482.
86. Parker SL, Leznoff A, Sussman GL, Tarlo SM, Krondl M. Characteristics of patients with food-related complaints. J Allergy Clin Immunol. 86:1990;503-511.
87. Pollock VE, Schneider LS. Topographic EEG in recovered depressed elderly. J Abnorm Psychol. 98:1989;268-273.
88. Pollock VE, Schneider LS. Topographic quantitative EEG in elderly subjects with major depression. Psychophysiology. 27:1990;438-444.
89. Post RM. Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am J Psychiatry. 149:1992;999-1010.
90. Prichep LS, John ER. qEEG profiles of psychiatric disorders. Brain Topogr. 4:1992;249-257.
91. Ray WJ, Cole HW. EEG alpha activity reflects attentional demands, and beta activity reflects emotional and cognitive processes. Science. 228:1985;750-752.
92. Reiss S, Peterson RA, Gursky DM, McNally RJ. Anxiety sensitivity, anxiety frequency, and the predictions of fearfulness. Behav Res Ther. 24:1986;1-8.
93. Retzlaff PD, Morris GL. Event-related potentials during the Continuous Visual Memory Test. J Clin Psychol. 52:1996;43-47.
94. Reynolds WM. Development of reliable and valid short forms of the Marlowe-Crowne Social Desirability Scale. J Clin Psychol. 38:1982;119-125.
95. Reynolds CF, Kupfer DJ, Taska LS, et al. EEG sleep in elderly depressed, demented, and healthy subjects. Biol Psychiatry. 20:1985;431-442.
96. Robinson TE, Berridge KC. The neural basis of drug craving An incentive-sensitization theory of addiction . Brain Res Rev. 18:1993;247-291.
97. Rosenthal NE, Genhardt M, Sack DA, Skwerer RG, Wehr TA. Seasonal affective disorder Relevance for treatment and research of bulimia . Hudson JA, Pope HG. Psychobiology of Bulimia. 1987;American Psychiatric Press, Washington, DC.
98. Ryan CM, Morrow LA, Hodgson M. Cacosmia and neurobehavioral dysfunction associated with occupational exposure to mixtures of organic solvents. Am J Psychiatry. 145:1988;1442-1445.
99. Schaffer CE, Davidson RJ, Saron C. Frontal and parietal electroencephalogram asymmetry in depressed and nondepressed subjects. Biol Psychiatry. 18:1983;753-762.
100. Schwartz GE, Bell IR, Dikman ZV, et al. EEG responses to low level chemicals in normals and cacosmics. Toxicol Ind Health. 10:1994;633-643.
101. Sills TL, Vaccarino FJ. Individual differences in sugar intake predict the locomotor response to acute and repeated amphetamine administration. Psychopharmacology. 116:1994;1-8.
102. Simon GE, Katon WJ, Sparks PJ. Allergic to life Psychological factors in environmental illness . Am J Psychiatry. 147:1990;901-906.
103. Simon GE, Daniell W, Stockbridge H, Claypoole K, Rosenstock L. Immunologic, psychological, and neuropsychological factors in multiple chemical sensitivity A controlled study . Ann Intern Med. 19:1993;97-103.
104. Sorg BA, Willis JR, Nowatka TC, Ulibarri C, See RE, Westberg HH. A proposed animal neurosensitization model for multiple chemical sensitivity in studies with formalin. Toxicology. 111:1996;135-145.
105. Sparks PJ, Daniell W, Black DW, et al. Multiple chemical sensitivity syndrome: A clinical perspective I. Case definition, theories of pathogenesis, and research needs . J Occup Med. 36:1994;718-730.
106. Staudenmayer H, Selner JC. Neuropsychophysiology during relaxation in generalized, universal "allergic' reactivity to the environment A comparison study . J Psychosom Res. 34:1990;259-270.
107. Stewart J, Badiani A. Tolerance and sensitization to the behavioral effects of drugs. Behav Pharmacol. 4:1993;289-312.
108. Szarek MJ, Bell IR, Schwartz GE (in press): Validation of a brief screening measure of environmental chemical sensitivity: The chemical odor intolerance index. J Environ Psychol.
109. Teicher MH, Glod CA, Surrey J, Swett C. Early childhood abuse and limbic system ratings in adult psychiatric outpatients. J Neuropsychiatry Clin Neurosci. 5:1993;301-306.
110. Terr AI. Multiple chemical sensitivities [editorial]. Ann Intern Med. 119:1993;163-164.
111. Valentino DA, Dufresne RL. Attention tasks and EEG power spectra. Int J Psychophysiol. 11:1991;299-301.
112. Visser SL, VanTilburg W, Hooijer C, Jonker C, DeRijke W. Visual evoked potentials (VEPs) in senile dementia (Alzheimer type) and in non-organic behavioral disorders in the elderly Comparison with EEG parameters . Electroencephalogr Clin Neurophysiol. 60:1985;115-121.
113. 2 agonist binding in the rat. Toxicology. 77:1993;223-232.
114. Von Euler G, Ogren S, Eneroth P, Fuxe K, Gustafsson J. Persistent effects of 80 ppm toluene on dopamine-regulated locomotor activity and prolactin secretion in the male rat. Neurotoxicology. 15:1994;621-624.
115. Wallace L, Nelson CJ, Kollander M, Leaderer B, Bascom R, Dunteman G (1991): Indoor air quality and work environment study. Multivariate statistical analysis of health, comfort, and odor perceptions as related to personal and workplace characteristics. US Environmental Protection Agency, vol 4, EPA Headquarters Buildings. Atmospheric Research and Exposure Assessment Laboratory, June 1991 (21M-3004).
116. Weinstein ND. Individual differences in reactions to noise A longitudinal study in a college dormitory . J Appl Psychol. 63:1978;458-466.
117. Woods DL, Knight RT. Electrophysiologic evidence of increased distractability after dorsolateral prefrontal lesions. Neurology. 36:1986;212-216.
118. Yehuda R, Southwick SM, Krystal JH, Bremner D, Charney DS, Mason JW. Enhanced suppression of cortisol following dexamethasone administration in posttraumatic stress disorder. Am J Psychiatry. 150:1993;83-86.
119. Yoshida K, Morimotor A, Makisumi T, Murakami N. Cardiovascular, thermal, and behavioral sensitization to metamphetamine in freely moving rats. J Pharmacol Exp Ther. 267:1993;1538-1543.
120. Yoshikawa T, Watanabe A, Shibuya H, Toru M. Involvement of the fimbria fornix in the initiation but not the expression of methamphetamine-induced sensitization. Pharmacol Biochem Behav. 45:1993;691-695.